Characterization of Fe3 O4/Au-Ag@MoS2 nanoparticles for brain cancer treatment using magneto plasmonic approach
Abstract
This study investigates the treatment of brain cancer by the magnetic hyperthermia approach and nanoparticles including Fe3 O4 core with gold, silver alloy shell, and MoS2 coating. Optical properties of these nanoparticles within the tumor, including the extinction coefficient and surface plasmon peak (SPR) as a function of size, structure, different compositions, and thickness are also investigated using the effective medium theory. Moreover, the impact of temperature distribution was assessed through the analytical modeling of alternating current (AC) magnetic field. The results of this study indicated that nanoparticles with a compound of Fe3 O4 - Au0.25 Ag0.75@MoS2 and a thickness of 3 nm of gold-silver alloy and 3 layers of MoS2 have the best coefficient of extinction and SPR in the biological window. The gold-silver alloy improved the extinction coefficient and, at the same time, prevented the accumulation of magnetic nanoparticles. Since the gold-silver alloy alone cannot function within the range of biological windows, MoS2 was used, which increased the extinction efficiency at higher wavelengths. Examination of the temperature distribution in the tumor for the proposed alloy compound indicated that after a short time from the start of irradiation, the tumor temperature reaches 45 C degree. Also, the temperature distribution within the tumor tissue reached its maximum value at the center of the tumor and decreased dramatically as getting away from the center. The use of magnetic hyperthermia enabled localized delivery of therapeutic dose to malignant brain tumors; hence, exhibiting superior performance/efficiency over the photothermal method.
Turn this paper into a lesson
ArcXiv compiles a structured reading guide from this paper's metadata: plain-English importance, contributions, prerequisite concepts, which sections to read first, flashcards, and a quiz. Grounded in the abstract, never invented.